We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+20.26%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.78B
AUM Growth
+$476M
Cap. Flow
+$105M
Cap. Flow %
3.79%
Top 10 Hldgs %
41.05%
Holding
1,048
New
64
Increased
345
Reduced
583
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$13.2M
2
NVDA icon
NVIDIA
NVDA
+$12.1M
3
AAPL icon
Apple
AAPL
+$11.4M
4
SHOP icon
Shopify
SHOP
+$9.06M
5
AVGO icon
Broadcom
AVGO
+$6.82M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$2.36M
2
ANET icon
Arista Networks
ANET
+$1.62M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.27M
4
XOM icon
ExxonMobil
XOM
+$1.24M
5
SNOW icon
Snowflake
SNOW
+$1.11M

Sector Composition

Rank Sector Weight
1 Technology 46.81%
2 Communication Services 11.24%
3 Consumer Discretionary 11.17%
4 Healthcare 8.46%
5 Financials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGAU
951
Centerra Gold
CGAU
$3.22B
$127K ﹤0.01%
17,610
-507
-3% -$3.47K
STOK icon
952
Stoke Therapeutics
STOK
$1.82B
$125K ﹤0.01%
10,986
-1,896
-15% -$18K
NG icon
953
NovaGold Resources
NG
$2.6B
$122K ﹤0.01%
29,918
+4,334
+17% +$16.2K
EXK
954
Endeavour Silver
EXK
$2.32B
$120K ﹤0.01%
24,298
+1,689
+7% +$6.65K
APLE icon
955
Apple Hospitality REIT
APLE
$3.96B
$119K ﹤0.01%
10,226
-27
-0.3% -$317
KALV
956
DELISTED
KalVista Pharmaceuticals
KALV
$113K ﹤0.01%
+10,020
New +$123K
ARVN icon
957
Arvinas
ARVN
$518M
$111K ﹤0.01%
15,122
-15,507
-51% -$114K
IOVA icon
958
Iovance Biotherapeutics
IOVA
$2.23B
$108K ﹤0.01%
62,848
-25,691
-29% -$63.9K
GT icon
959
Goodyear
GT
$2.07B
$108K ﹤0.01%
10,389
-1,067
-9% -$11.3K
RGNX icon
960
Regenxbio
RGNX
$623M
$106K ﹤0.01%
+12,921
New +$108K
EBS icon
961
Emergent Biosolutions
EBS
$375M
$105K ﹤0.01%
16,488
-5,504
-25% -$31.5K
LXP icon
962
LXP Industrial Trust
LXP
$3.53B
$103K ﹤0.01%
2,491
-102
-4% -$4.2K
VIAV icon
963
Viavi Solutions
VIAV
$9.75B
$102K ﹤0.01%
10,136
+91
+0.9% +$880
CAPR icon
964
Capricor Therapeutics
CAPR
$1.14B
$102K ﹤0.01%
10,241
-6,867
-40% -$72.5K
EOLS icon
965
Evolus
EOLS
$394M
$99.8K ﹤0.01%
+10,833
New +$111K
PUMP icon
966
ProPetro Holding
PUMP
$1.45B
$99.1K ﹤0.01%
16,603
-3,975
-19% -$22.7K
TRVI icon
967
Trevi Therapeutics
TRVI
$2.49B
$98.8K ﹤0.01%
+18,059
New +$112K
NUVB icon
968
Nuvation Bio
NUVB
$2.24B
$92.8K ﹤0.01%
47,597
+7,123
+18% +$14.8K
PAYO icon
969
Payoneer
PAYO
$2.41B
$91K ﹤0.01%
13,286
+953
+8% +$6.46K
VSTM icon
970
Verastem
VSTM
$532M
$90.1K ﹤0.01%
+21,708
New +$136K
MDXG icon
971
MiMedx Group
MDXG
$626M
$89.5K ﹤0.01%
14,654
-525
-3% -$3.49K
RES icon
972
RPC Inc
RES
$1.24B
$89.2K ﹤0.01%
18,864
-208
-1% -$1K
DFTX
973
Definium Therapeutics
DFTX
$5.73B
$89K ﹤0.01%
13,707
-3,802
-22% -$25K
ALT icon
974
Altimmune
ALT
$539M
$84K ﹤0.01%
21,713
-8,046
-27% -$43.5K
HUMA icon
975
Humacyte
HUMA
$168M
$81.8K ﹤0.01%
39,153
+854
+2% +$1.64K
37 38
39
40 41

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Profund Advisors held 1,048 positions worth $2.78B, up 21% from $2.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors deployed $105M of net new capital in Q2 2025, opening 64 new positions and adding to 345 existing holdings. Its largest new stake was Shopify: 90,613 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 41% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Salesforce, an estimated $2.36M trimmed.

  • Profund Advisors's largest Q2 2025 buy was Shopify: 90,613 shares worth $10.5M.
  • Profund Advisors added most to Microsoft in Q2 2025, an estimated $13.2M increase.
  • Profund Advisors's biggest Q2 2025 reduction was Salesforce, cutting an estimated $2.36M.
  • Profund Advisors fully exited MongoDB in Q2 2025, selling an estimated $848K.
  • Profund Advisors's ten largest holdings make up 41% of its $2.78B portfolio in Q2 2025.
  • Profund Advisors opened 64 new positions and closed 56 in Q2 2025.
  • Profund Advisors's portfolio value rose 21% quarter-over-quarter to $2.78B.

Based on Profund Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.